The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Полную версию статьи можно прочитать на сайте источника:
Читать »
Криптовалюты
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
29 июля 2025, 18:42
Источник: cointelegraph
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
